| Stage | OKE | % of rev | CPK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12.5B | 100.00% | $202M | 100.00% | OKE ×61.69 |
| Gross profit | $2.8B | 22.83% | $150M | 74.39% | CPK +51.6pp |
| Operating income | $1.6B | 12.59% | $53M | 26.20% | CPK +13.6pp |
| Pre-tax income | $1.4B | 10.90% | $35M | 17.34% | CPK +6.4pp |
| Net income | $1.4B | 11.11% | $25M | 12.58% | CPK +1.5pp |
| Stage | OKE | CPK | Gap · A − B |
|---|---|---|---|
| Revenue | $12.5B100.00% | $202M100.00% | OKE ×61.69 |
| Gross profit | 22.83%$2.8B | 74.39%$150M | CPK +51.6pp |
| Operating income | 12.59%$1.6B | 26.20%$53M | CPK +13.6pp |
| Pre-tax income | 10.90%$1.4B | 17.34%$35M | CPK +6.4pp |
| Net income |
| 11.11%$1.4B |
| 12.58%$25M |
| CPK +1.5pp |
No shared counterparties.